Delivery Order SPE2DB24D9113-SPE2DB25FEPZY

Award Date 5/9/25
Potential Completion Date 6/2/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $9,251.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is to provide 4,567,552,642 units of BOTOX 100 UNIT VIALS to support the medical supply needs of military healthcare facilities. This delivery order is issued under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Firm Fixed Price Delivery Order valued at $22,034.40 and has an ultimate completion date of May 13, 2025. The contract is for the delivery of 4,568,037,211 units of Botox 200 unit vials. This contract is not associated with a set-aside and is part of a larger Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,845.92 contract is for the supply of BOTOX 100 unit vials, with a period of performance through August 8, 2024. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, valued at up to $499,999,999. The...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $11,075.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,564,258,790 units of Botox 100 unit vials, with an ultimate completion date of May 1, 2024. This delivery order is part of a larger $4,999,999 indefinite delivery, indefinite quantity (IDIQ) contract that DMS Pharmaceutical Group...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,771.50, is for the delivery of 4,568,012,828 units of Botox 200 unit vials. The contract is a firm fixed-price delivery order with a period of performance ending on May 13, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the...
This federal contract award, valued at $13,844.40, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for 4,564,828,313 units of Botox 100 unit vials, with a period of performance through June 27, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,319.49, is for the provision of 4,559,056,548 units of Botox 100-unit vials. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,537.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4565933217 units of BOTOX 100 UNIT VIALS to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) that DMS Pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
  • SPE2DB24D9113
    Indefinite Delivery Contract
  • SPE2DB24D9113-SPE2DB25FEPZY
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order worth $4,625.70 with a firm fixed price and an ultimate completion date of June 2, 2025. The contract is for the delivery of 4,568,243,809 units of Botox 100 unit vials. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group has consistently secured federal contracts without specific set-aside designations, leveraging its status as a woman-owned small business.

Generated 8/8/25, 10:07 AM